Improving diversity in clinical research for patients undergoing surgery (PROTECT-DIVERSITY)

ISRCTN ISRCTN14173025
DOI https://doi.org/10.1186/ISRCTN14173025
Integrated Research Application System (IRAS) 350756
Central Portfolio Management System (CPMS) 65329
Grant Code WKR0-2023-0016
Sponsor Queen Mary University of London
Funders British Journal of Anaesthesia, Academy of Medical Sciences
Submission date
26/11/2025
Registration date
04/12/2025
Last edited
04/12/2025
Recruitment status
Not yet recruiting
Overall study status
Ongoing
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
The lack of diversity in clinical trials is an important issue, which limits external validity. We are doing this study to check whether consent forms in several different languages can improve access to research for patients having surgery. We will also compare the accuracy and completeness of diversity data collection using different methods such as in your medical records, as part of questionnaires and by asking participants questions.

Who can participate?
Adults aged 18 years and over undergoing elective surgery.

What does the study involve?
Patients will be asked to consent to be part of the PROTECT Trial. The consent materials will either be in a traditional paper format or an electronic format, assigned at random. Information such as sex, ethnicity, partnership status, disability, pregnancy status, religion, sexual orientation, gender and gender identity will be collected as part of the PROTECT trial, and patients can refuse to answer any questions they do not want to.

What are the possible benefits and risks of participating?
The information collected may improve how we collect diversity information for patients taking part in clinical trials in the future. There are no disadvantages to taking part in this study.

Where is the study run from?
Queen Mary University of London (UK)

When is the study starting and how long is it expected to run for?
The study is starting in December 2025 and will run for 2 years.

Who is funding the study?
The British Journal of Anaesthesia and the Academy of Medical Sciences

Who is the main contact?
Dr Tom Abbott, protect-admin@qmul.ac.uk

Contact information

Dr Tom Abbot
Scientific, Public, Principal investigator

Royal London Hospital
London
E1 1FR
United Kingdom

Phone +44 203 594 0348
Email t.abbott@qmul.ac.uk

Study information

Primary study designInterventional
AllocationRandomized controlled trial
MaskingOpen (masking not used)
ControlActive
AssignmentSingle
PurposeHealth services research
Scientific titleDiversity in perioperative research
Study acronymPROTECT-DIVERSITY
Study objectives1. Compare the impact of using multi-lingual consent forms with consent forms in English on the ethnic diversity of patients included in the study.
2. Compare the accuracy and completeness of protected characteristics data collection using different methods.
Ethics approval(s)

Approved 10/02/2025, London – South East Research Ethics Committee (2 Redman Place, Stratford, London, E20 1JQ, United Kingdom; +44 207 104 8222; londonsoutheast.rec@hra.nhs.uk), ref: 24/LO/0887

Health condition(s) or problem(s) studiedAdult patients undergoing elective surgery
InterventionThe master protocol is registered at https://www.isrctn.com/ISRCTN14639555

The method of informed consent will use either an electronic or paper method, which is consistent with the master protocol. For this comparison, the mode of consent (electronic or paper) will be determined at random before approaching the patient, which includes consent for entry into the platform. Since the intervention in question is the process of consent, it will not be possible to obtain consent before the ‘intervention’ i.e. the consent process. In this case, there will be a waiver of consent to randomise to intervention or usual care (electronic consent or paper consent). After randomisation, the patient will complete the consent process using either electronic multi-lingual consent documents or paper consent documents in English, according to group allocation. This process supersedes the procedure for timing of informed consent detailed in the master protocol section nine, which will apply to consent for inclusion in the platform (master protocol) and this comparison. Electronic consent materials will be translated into Polish, Romania, Panjabi, Urdu and Portuguese, which are the five most common languages for people where English/Welsh is not their first language. Translations will be undertaken by an approved/certified provider
Intervention typeOther
Primary outcome measure(s)

Reciprocal diversity index for ethnicity on a scale of 0 to 100 at end of trial

Key secondary outcome measure(s)

1. Completeness of data collection for protected characteristics at trial end
2. Degree of agreement for protected characteristics data between data collection modalities at trial end

Completion date01/02/2027

Eligibility

Participant type(s)Patient
Age groupMixed
Lower age limit18 Years
Upper age limit100 Years
SexAll
Target sample size at registration532
Key inclusion criteria1. Patients aged 18 years and over undergoing elective surgery
Key exclusion criteria1. Inability to provide informed consent
2. Co-enrolment in PROTECT CTIMP comparisons
3. Previous enrolment to the PROTECT-DIVERSITY comparison
Date of first enrolment01/02/2026
Date of final enrolment01/01/2027

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Barts Health NHS Trust
The Royal London Hospital
80 Newark Street
London
E1 2ES
England

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Other files Consent form 19/06/2025 01/12/2025 No No
Protocol file version 3.0 19/06/2025 01/12/2025 No No

Additional files

48563 PROTECT-DIVERSITY Participant Informed Consent Form 2.0 19.06.2025 clean.pdf
Consent form
48563 PROTECT-DIVERSITY Protocol 19.06.2025 v3.0.pdf
Protocol file

Editorial Notes

26/11/2025: Study's existence confirmed by the NIHR.